BioMed Up:
Investment in Life Science Start-ups
Geneva Biotech Campus, Geneva, March 12 2014, starting at 18.00
The INSEAD Swiss Healthcare Industry Club (cHIC) is extending partnerships with the EPFL A3 Angels, the Business Angels and the Mentoring Club of EPFL alumni. The Geneva Biotech Campus is located in the former Merck Serono building in Geneva.
[important]Tickets on Xing http://de.amiando.com/BiomedUp.html[/important]Conference theme, speakers and debate approach
How can Angel investors support life science start-ups with capital, expertise? Switzerland is a hot-bed for the development of life sciences technologies and ranked first in the INSEAD Global Innovation Index 2012. However, the financing opportunities for life science startups have eroded, as described in Ernst & Young’s “Pulse of the industry report” 2013. Venture capital investment was down 21% in 2012-13 to its lowest level in more than a decade. The Swiss Commission for Technology and Innovation, SECA and CTI-Invest are encouraging private investment from Business Angels to fill the gap. We will address these opportunities and challenges with an outstanding panel of experts and in presence of several Swiss start-up companies:
Key trends in medtech and biotech investments seen by experts including:
- Angelo De Rosa, Director, Strategy & Business Development at Medtronic
- David Deperthes, Vice President Business Development Debiopharm
- Benoît Dubuis, Director Wyss Center for Bio and Neuroengineering
- Frank Kumli, Ernst & Young Healthcare practice
Ask your questions to a panel featuring highly successful entrepreneurs:
- Nicolas Durand, Founder at Abionic,
- Vital Verin, founder Endosense and Mestro-Heart,
- Jean-Pierre Rosat, CEO at Aleva Neurotherapeutics,
- Jean-Marc Wismer, CEO Sensimed.
- Moderated by Nafida Bendali, Investor relations consultant in life sciences
The attendance fee is CHF 75 per person. [notice]The seating is limited![/notice]
